Skip to main content

Table 1 Participants biomarkers and symptom levels on both diets, high salicylate and low salicylate

From: Effect of low salicylate diet on clinical and inflammatory markers in patients with aspirin exacerbated respiratory disease – a randomized crossover trial

  Baseline HS LS  
Post Δ High Post Δ Low Δ High x Δ Low
Median IQR Median IQR Median IQR Median IQR Median IQR p
Urinary SA 2.62 4.5 0.92 0.8 −1.7 3.0 0.6 3.4 −1.13 2.1 0.338
Urinary SU 37.9 45.6 23.82 54.3 −16.76 31.6 44.21 34.6 −7.35 19.3 0.482
Urinary CysLT 819.88 2649.6 771.99 1327.9 − 173.17 1065.2 874.05 1221.4 − 184.58 1518.9 0.949
Urinary Cr 10.3 11.3 *15.3 12.6 2.6 8.4 9.9 11.3 −0.3 11.1 0.655
SNOT - 22 66 40 64 40 7 15 *44 31 −10 24 0.013
  1. HS High-Salicylate Diet, LS Low-Salicylate Diet, SA Salicylic Acid (ng/ml), SU Salicyluric Acid (ng/ml), CysLT Cysteinyl leukotrienes (pg/ml), Cr Creatine (mmol/L), SNOT − 22 Sino-nasal outcome test, Δ High Post - Baseline of High-Salicylate diet group, Δ Low Post - Baseline of Low-salicylate diet group. * significance p ≤ 0.05 (Wilcoxon Test; baseline x post); Δ High x Δ Low = intergroup dietary effect comparison (Mann Whitney U test)